Prestige Biologics Co Ltd
334970
Company Profile
Business description
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).
Contact
197, Osongsaengmyeong 1-ro
Osong-eup, Heungdeok-gu
Chungcheongbuk-do
Cheongju-si28161
KORT: +82 432321552
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
250
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,961.70 | 8.20 | -0.10% |
| CAC 40 | 7,329.97 | 5.43 | -0.07% |
| DAX 40 | 21,311.02 | 57.32 | 0.27% |
| Dow JONES (US) | 39,669.39 | 699.57 | -1.73% |
| FTSE 100 | 8,275.60 | 26.48 | 0.32% |
| HKSE | 21,056.98 | 409.29 | -1.91% |
| NASDAQ | 16,307.16 | 516.01 | -3.07% |
| Nikkei 225 | 33,920.40 | 347.14 | -1.01% |
| NZX 50 Index | 12,067.92 | 56.58 | 0.47% |
| S&P 500 | 5,275.70 | 120.93 | -2.24% |
| S&P/ASX 200 | 7,758.90 | 2.80 | -0.04% |
| SSE Composite Index | 3,276.00 | 8.34 | 0.26% |